Treatment of type 1 diabetes (T1D) is entering a transformative era. The first immunotherapy approved to delay clinical onset—Teplizumab—has received FDA approval in the United S...
With the rapid development of precision medicine, targeted drugs have become a key approach in cancer treatment. Unlike traditional chemotherapy, targeted therapy “hits” specific...